Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of life saving
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    601 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 37
    602 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 57
    603 Apheresis Allogeneic Thalassemia Major Hematology 2026 Standard Therapy Turkey 1
    604 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 59
    605 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Switzerland 65
    606 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 28
    607 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Estonia 67
    608 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Czechia 28
    609 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 71
    610 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 73
    611 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 73
    612 Apheresis Allogeneic Acute Myeloblastic Leukemia Hematology 2026 Standard Therapy Romania 62
    613 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 62
    614 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy USA 52
    615 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 71
    616 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Spain 48
    617 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy USA 59
    618 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 52
    619 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 43
    620 Apheresis Allogeneic Akut Myeloid Leukemia Hematology 2026 Standard Therapy Turkey 48
    621 Apheresis Allogeneic Chronic myelomonocytic leukemia Hematology 2026 Standard Therapy Finland 16
    622 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 30
    623 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy Germany 72
    624 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 50
    625 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 70
    626 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Spain 45
    627 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 75
    628 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 39
    629 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy USA 32
    630 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Argentina 34
    631 Apheresis Allogeneic Other Malignancy, Specify Hematology 2026 Standard Therapy USA 68
    632 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Switzerland 63
    633 Apheresis Allogeneic T-Cell Non-Hodgkin lymphoma Hematology 2026 Standard Therapy Argentina 70
    634 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Czechia 52
    635 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy France 62
    636 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 20
    637 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 53
    638 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 56
    639 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 71
    640 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy USA 54
    641 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Hungary 36
    642 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 47
    643 Apheresis Autologus Diffuse Large B-Cell Lymphoma hematology 2026 Standard Therapy Germany 65
    644 Apheresis Autologus Multiple Myeloma hematology 2026 Standard Therapy Germany 59
    645 Apheresis Autologus Multiple Myeloma hematology 2026 Standard Therapy Germany 59
    646 Apheresis Autologus Multiple Myeloma hematology 2026 Standard Therapy Germany 59
    647 Apheresis Autologus Diffuse Large B-Cell Lymphoma hematology 2026 Standard Therapy Germany 63
    648 Apheresis Autologus Multiple Myeloma hematology 2026 Standard Therapy Germany 37
    649 Apheresis Autologus Multiple Myeloma hematology 2026 Standard Therapy Germany 61
    650 Apheresis Autologus Multiple Myeloma hematology 2026 Standard Therapy Germany 63
    651 Apheresis Allogeneic CMMOL-AML hematology 2026 Standard Therapy Hungary 47
    652 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Spain 52
    653 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 53
    654 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Poland 61
    655 Apheresis Allogeneic Other Non-Malignant Disease hematology 2026 Standard Therapy USA 67
    656 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Germany 3
    657 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 38
    658 Apheresis Allogeneic Prolymphocytic Leukemia hematology 2026 Standard Therapy United Kingdom 60
    659 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Poland 70
    660 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 48
    661 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy France 60
    662 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy USA 51
    663 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Chile 6
    664 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 56
    665 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy USA 69
    666 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy USA 41
    667 Apheresis Allogeneic Chronic Myelomonocytic Leukemia hematology 2026 Standard Therapy United Kingdom 66
    668 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Italy 65
    669 Apheresis Allogeneic Acute Lymphoblastic Leukemia hematology 2026 Standard Therapy Germany 49
    670 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy USA 76
    671 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Italy 61
    672 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Poland 4
    673 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy USA 65
    674 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Poland 59
    675 Apheresis Allogeneic Chronic Myelomonocytic Leukemia hematology 2026 Standard Therapy Germany 50
    676 Apheresis Allogeneic Myelodysplastic/Myeloproliferative Neoplasms hematology 2026 Standard Therapy Poland 69
    677 Apheresis Allogeneic Hodgkin Lymphoma hematology 2026 Standard Therapy USA 48
    678 Apheresis Allogeneic Prolymphocytic Leukemia hematology 2026 Standard Therapy USA 71
    679 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy United Kingdom 55
    680 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 59
    681 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy United Kingdom 62
    682 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy France 65
    683 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Germany 75
    684 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 57
    685 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 72
    686 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 32
    687 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Bulgaria 63
    688 Apheresis Allogeneic Myelofibrosis hematology 2026 Standard Therapy Hungary 52
    689 Apheresis Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Germany 64
    690 Apheresis Allogeneic Non-Hodgkin Lymphoma hematology 2026 Standard Therapy Poland 24
    691 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 59
    692 Apheresis Allogeneic Non-Hodgkin Lymphoma hematology 2026 Standard Therapy Belgium 65
    693 Apheresis Allogeneic Chronic Myelomonocytic Leukemia hematology 2026 Standard Therapy USA 65
    694 Apheresis Allogeneic Acute Lymphoblastic Leukemia hematology 2026 Standard Therapy USA 47
    695 Apheresis Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Sweden 21
    696 Apheresis Autologous Multiple Myeloma hematology 2026 Standard Therapy Portugal 57
    697 Apheresis Autologous Multiple Myeloma hematology 2026 Standard Therapy Portugal 68
    698 Cord Tissue Allogeneic – Related Chronic renal disease Endocrinology 2025 Experimental Therapy Romania 50
    699 Cord Tissue Allogeneic – Related Autism Neurology 2025 Experimental Therapy Romania 6
    700 Cord Tissue Autologous Autism Neurology 2025 Experimental Therapy Romania 6